NUNZ — Nunzia Pharmaceutical Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.15m
Annual cashflow statement for Nunzia Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | C2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0 | -0.013 | -0.019 | -101 | -78.1 |
| Non-Cash Items | 0 | 0 | -0.009 | 101 | 78 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0 | 0.013 | 0.027 | 0.005 | -0.024 |
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 0 | 0 | 0 | -0.032 | -0.087 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | — | 0.032 | 0.087 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0 | 0 | 0 |